Ultime notizie per Allakos (NASDAQ:ALLK) Azioni

Allakos

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.

Allakos Inc

Allkem Ltd

WIIM

MSGM

Motorsport Games shares are trading higher. The company announced it field for a mixed shelf offering worth up to $100 million.

<p>TD Cowen  analyst David Deckelbaum   maintains California Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRC#NYSE">CRC</a>) with a Buy and raises the price target from $65 to $74.</p>


News

Price Target

Analyst Ratings

TD Cowen Maintains Buy on California Resources, Raises Price Target to $74

<p>Deep-pocketed investors have adopted a bearish approach towards Core Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CORZ usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 19 extraordinary options activities for Core Scientific. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 31% leaning bullish and 52% bearish. Among these notable options, 2 are puts, totaling $262,518, and 17 are calls, amounting to $1,140,693.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $15.0 to $25.0 for Core Scientific over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In today's trading context, the average open interest for options of Core Scientific stands at 8703.14, with a total volume reaching 10,523.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Core Scientific, situated within the strike price corridor from $15.0 to $25.0, throughout the last 30 days.</p>
<h3>Core Scientific Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732642254_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CORZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.9</td>
<td>$3.8</td>
<td>$3.8</td>
<td>$15.00</td>
<td>$210.1K</td>
<td>20.6K</td>
<td>1.1K</td>
</tr>
<tr>
<td>CORZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.9</td>
<td>$3.8</td>
<td>$3.85</td>
<td>$15.00</td>
<td>$209.7K</td>
<td>20.6K</td>
<td>586</td>
</tr>
<tr>
<td>CORZ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$0.45</td>
<td>$0.4</td>
<td>$0.4</td>
<td>$16.00</td>
<td>$200.4K</td>
<td>1.5K</td>
<td>5.0K</td>
</tr>
<tr>
<td>CORZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$4.9</td>
<td>$4.7</td>
<td>$4.7</td>
<td>$20.00</td>
<td>$102.9K</td>
<td>3.0K</td>
<td>220</td>
</tr>
<tr>
<td>CORZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$2.95</td>
<td>$2.85</td>
<td>$2.85</td>
<td>$21.00</td>
<td>$73.8K</td>
<td>472</td>
<td>13</td>
</tr>
</tbody>
</table>
</p>
<h3>About Core Scientific</h3>
<p>Core Scientific Inc is engaged in Blockchain and AI Infrastructure, Digital Asset Self-Mining, Premium Hosting, Blockchain Technology, and Artificial Intelligence related services. The business operates in two segments being; Equipment Sales and Hosting which consists of blockchain infrastructure, third-party hosting business and equipment sales to customers. Mining segment consists of digital asset mining for its account. The blockchain business generates revenue from the sale of consumption-based contracts and by providing hosting services. The digital asset mining segment earns revenue from operating a firm's owned computer equipment as part of a pool of users that process transactions conducted on one or more blockchain networks. In exchange, it receives digital currency assets.</p>
<p>Having examined the options trading patterns of Core Scientific, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of Core Scientific</h3>
<ul>
<li>With a trading volume of 3,603,883, the price of CORZ is up by 0.52%, reaching $18.2.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 105 days from now.</li>
</ul>
<h3>Expert Opinions on Core Scientific</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $20.1.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Macquarie has decided to maintain their Outperform rating on Core Scientific, which currently sits at a price target of $19.<br />
&#x2A; In a cautious move, an analyst from Roth MKM downgraded its rating to Buy, setting a price target of $25.<br />
&#x2A; In a cautious move, an analyst from Jefferies downgraded its rating to Buy, setting a price target of $19.<br />
&#x2A; An analyst from Needham has decided to maintain their Buy rating on Core Scientific, which currently sits at a price target of $18.<br />
&#x2A; An analyst from BTIG persists with their Buy rating on Core Scientific, maintaining a target price of $19. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Core Scientific, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

Core Scientific, Inc. - Class A Common Stock

CORZ

Core Scientific's Options: A Look at What the Big Money is Thinking

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>IonQ</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with IONQ, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 22 uncommon options trades for IonQ.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 40% bullish and 45%, bearish.</p>
<p>Out of all of the special options we uncovered, 7 are puts, for a total amount of $600,500, and 15 are calls, for a total amount of $1,230,325.</p>
<h3>Predicted Price Range</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $12.5 to $45.0 for IonQ over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for IonQ's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of IonQ's whale trades within a strike price range from $12.5 to $45.0 in the last 30 days. </p>
<h3>IonQ Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732642249_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$4.7</td>
<td>$4.5</td>
<td>$4.53</td>
<td>$35.00</td>
<td>$587.9K</td>
<td>9.0K</td>
<td>1.3K</td>
</tr>
<tr>
<td>IONQ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$14.1</td>
<td>$14.0</td>
<td>$14.0</td>
<td>$45.00</td>
<td>$284.2K</td>
<td>0</td>
<td>206</td>
</tr>
<tr>
<td>IONQ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$10.8</td>
<td>$10.5</td>
<td>$10.5</td>
<td>$35.00</td>
<td>$141.7K</td>
<td>674</td>
<td>140</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$3.0</td>
<td>$2.83</td>
<td>$2.9</td>
<td>$40.00</td>
<td>$58.0K</td>
<td>2.3K</td>
<td>451</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$13.95</td>
<td>$12.7</td>
<td>$13.95</td>
<td>$35.00</td>
<td>$55.8K</td>
<td>2.7K</td>
<td>128</td>
</tr>
</tbody>
</table>
</p>
<h3>About IonQ</h3>
<p>IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems, and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.</p>
<p>Following our analysis of the options activities associated with IonQ, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of IonQ</h3>
<ul>
<li>Currently trading with a volume of 16,335,216, the IONQ's price is up by 2.46%, now at $31.64. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 92 days.</li>
</ul>
<h3>Expert Opinions on IonQ</h3>
<p>A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $20.666666666666668.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Craig-Hallum keeps a Buy rating on IonQ with a target price of $22.<br />
&#x2A; Maintaining their stance, an analyst from Needham continues to hold a Buy rating for IonQ, targeting a price of $18.<br />
&#x2A; An analyst from Benchmark has decided to maintain their Buy rating on IonQ, which currently sits at a price target of $22. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for IonQ with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


IONQ

What the Options Market Tells Us About IonQ

Trading Ideas

Live On CNBC, Bill Baruch Announces Bought Intercontinental Exchange

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Dollar Gen</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with DG, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 11 uncommon options trades for Dollar Gen.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 36% bullish and 54%, bearish.</p>
<p>Out of all of the special options we uncovered, 4 are puts, for a total amount of $154,980, and 7 are calls, for a total amount of $341,006.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $60.0 to $86.0 for Dollar Gen over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Dollar Gen stands at 882.43, with a total volume reaching 2,603.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Dollar Gen, situated within the strike price corridor from $60.0 to $86.0, throughout the last 30 days.</p>
<h3>Dollar Gen Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732642244_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$5.1</td>
<td>$4.95</td>
<td>$5.05</td>
<td>$75.00</td>
<td>$75.7K</td>
<td>41</td>
<td align="right">903</td>
</tr>
<tr>
<td>DG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/06/24</td>
<td>$5.3</td>
<td>$5.05</td>
<td>$5.1</td>
<td>$75.00</td>
<td>$68.8K</td>
<td>41</td>
<td align="right">137</td>
</tr>
<tr>
<td>DG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$5.05</td>
<td>$4.95</td>
<td>$5.05</td>
<td>$75.00</td>
<td>$50.5K</td>
<td>41</td>
<td align="right">352</td>
</tr>
<tr>
<td>DG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.7</td>
<td>$6.7</td>
<td>$6.7</td>
<td>$75.00</td>
<td>$47.5K</td>
<td>3.7K</td>
<td align="right">81</td>
</tr>
<tr>
<td>DG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$4.65</td>
<td>$4.65</td>
<td>$4.65</td>
<td>$80.00</td>
<td>$42.7K</td>
<td>1.2K</td>
<td align="right">62</td>
</tr>
</tbody>
</table>
</p>
<h3>About Dollar Gen</h3>
<p>With more than 20,000 locations, Dollar General's banner is nearly ubiquitous across the rural United States. Dollar General serves as a convenient shopping destination for fill-in store trips, with its value proposition most relevant to consumers in small communities with a dearth of shopping options. The retailer operates a frugal store of about 7,500 square feet and primarily offers an assortment of branded and private-label consumable items (80% of net sales) such as paper and cleaning products, packaged and perishable food, tobacco, and health and beauty items at low prices. Dollar General also offers a limited assortment of seasonal merchandise, home products, and apparel. The firm sells most items at a price point of $10 or less.</p>
<p>Having examined the options trading patterns of Dollar Gen, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of Dollar Gen</h3>
<ul>
<li>Currently trading with a volume of 1,112,546, the DG's price is down by -2.35%, now at $74.79. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 9 days.</li>
</ul>
<h3>What The Experts Say On Dollar Gen</h3>
<p>3 market experts have recently issued ratings for this stock, with a consensus target price of $84.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from JP Morgan has decided to maintain their Neutral rating on Dollar Gen, which currently sits at a price target of $82.<br />
&#x2A; Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on Dollar Gen with a target price of $90.<br />
&#x2A; Maintaining their stance, an analyst from BMO Capital continues to hold a Market Perform rating for Dollar Gen, targeting a price of $80. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Dollar Gen, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Dollar Gen Unusual Options Activity

ENSC

Ensysce Biosciences shares are trading higher after the company announced treatment for its first group of subjects in the PF614-MPAR-102 study.

Live On CNBC, Stephanie Link Announces Bought Accenture

<p>TD Cowen  analyst Steven Mah   reiterates Twist Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>) with a Buy and maintains $58 price target.</p>


Reiteration

TWST

TD Cowen Reiterates Buy on Twist Bioscience, Maintains $58 Price Target

<p>Amazon solidified its position as the go-to destination for holiday shoppers this year, with consumer spending trends signaling a robust holiday <a href="https://www.benzinga.com/news/econ-s">season despite economic uncertainties. </a></p>
<p>According to Goldman Sachs&#8217; 2024 Holiday Survey, authored a team of analysts led by <strong>Brooke Roach</strong>, CFA, 35% of U.S. consumers indicated <strong>Amazon.com Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) as their top choice for holiday spending, marking a notable year-over-year (Y/Y) increase, and outpacing other retail giants like <strong>Walmart Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), <strong>Target Corp.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>), and <strong>Costco</strong> <strong>Wholesale Corp. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>).</p>
<h1 class="wp-block-heading"><strong>Amazon, Walmart Lead, But The Gap Widens</strong></h1>
<p>Amazon and Walmart continue to be the two most preferred retailers during the holiday season.</p>
<p>Walmart, while holding its ground as the second most popular choice, experienced a slight decline in preference, along with Best Buy. Meanwhile, Target and Costco trailed behind but posted modest gains in their share of consumer spending intent.</p>
<p>The shift reflects Amazon&#8217;s growing dominance in online retail, bolstered by early promotional events such as its July and October Prime Days.</p>
<p>These events appear to have captured consumer attention early, with over half of shoppers starting their holiday shopping before Thanksgiving — a trend consistent with previous years.</p>
<h1 class="wp-block-heading"><strong>Online Shopping Remains King</strong></h1>
<p>E-commerce remains the reigning channel for holiday purchases, with more consumers opting to shop online this year compared to 2023. </p>
<p>"Online shopping remains the preferred shopping channel," the report stated. </p>
<p>The survey revealed that 45% of male consumers and 38% of female consumers plan to do the majority of their shopping digitally — a two percentage point increase Y/Y for both groups.</p>
<p>Younger demographics are driving this trend: Over 50% of Gen Z and Millennial shoppers said they plan to complete the bulk of their holiday shopping online, favoring the convenience of digital platforms. </p>
<p>"Electronics saw the largest increase in consumer preference for online shopping compared to last year (+4pts Y/Y), followed by gift cards, media and experiential gifts (all +3pts Y/Y)," Goldman Sachs wrote. </p>
<h1 class="wp-block-heading"><strong>Black Friday Is Back in Style</strong></h1>
<p>While early shopping trends are on the rise, Black Friday continues to hold its ground as a pivotal moment in the holiday shopping season. The survey showed a two-point increase in the number of consumers planning to complete their holiday shopping on or before Black Friday compared to last year and an 11-point jump compared to 2019.</p>
<p>This year, the calendar provides an added boost: Black Friday falls five days later than in 2023, giving shoppers additional time to prepare. </p>
<p>Notably, low-income consumers remain the most likely to take advantage of Black Friday deals, emphasizing the importance of sales and promotions in driving their spending decisions.</p>
<p><strong>Read Now:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/etfs/currency-etfs/24/11/42190765/trumps-tariff-threats-slam-mexican-peso-canadian-dollar-only-the-beginning-of-a-sorely-needed-repricing-expert-warns">Mexican Peso, Canadian Dollar Slide As Ackman Says Trump Will Use Tariffs &#8216;As A Weapon&#8217;</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Psychology

AMZN

COST

Amazon Dominates Holiday Shopping As Black Friday Spending Soars: Goldman Sachs

<p>TD Cowen  analyst Jason Gabelman   maintains Cheniere Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>) with a Buy and raises the price target from $202 to $242.</p>


TD Cowen Maintains Buy on Cheniere Energy, Raises Price Target to $242

UCloudlink Group shares are trading lower after the company reported worse-than-expected Q3 sales results.

Office Properties Income Trust shares are trading higher. The company announced a debt refinancing plan for up to $340 million in senior unsecured notes

<p>B. Riley Securities  analyst Naved Khan   maintains ACV Auctions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACVA#NASDAQ">ACVA</a>) with a Buy and raises the price target from $24 to $27.</p>


ACVA

B. Riley Securities Maintains Buy on ACV Auctions, Raises Price Target to $27

<p>Raymond James  analyst Savanthi Syth   reiterates Vertical Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVTL#NYSE">EVTL</a>) with a Market Perform.</p>


EVTL

Raymond James Reiterates Market Perform on Vertical Aerospace

<p>B. Riley Securities  analyst Hal Goetsch   maintains Shift4 Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) with a Buy and raises the price target from $110 to $150.</p>


FOUR

B. Riley Securities Maintains Buy on Shift4 Payments, Raises Price Target to $150

<p>B. Riley Securities  analyst Craig Kennison   maintains Semtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) with a Buy and raises the price target from $61 to $85.</p>


SMTC

B. Riley Securities Maintains Buy on Semtech, Raises Price Target to $85

Real Good Food Company shares are trading higher. The company requested an extension regarding its Nasdaq delinquency notice.

<h3><strong>The partnership will connect advertisers in a privacy-protective manner to SMB audiences to create more accurate and better-performing B2B marketing campaigns</strong></h3>
<p><strong>REDWOOD CITY, Calif – November 26, 2024</strong>&nbsp;– PubMatic, an independent technology company delivering digital advertising's supply chain of the future, announced a new strategic partnership with Intuit's SMB MediaLabs that will make rich first-party SMB audiences available in PubMatic's self-service Convert platform for commerce media. This collaboration will enable publishers and advertisers to access unparalleled data-led targeting capabilities, significantly enhancing B2B marketing campaign performance and accuracy.</p>
<p>Intuit's SMB MediaLabs is a first-of-its-kind media network focused solely on small and medium-sized businesses. It reaches an audience of millions of small and medium businesses leveraging 36 million identifiers through Intuit QuickBooks, while keeping the underlying customer data secure on Intuit's platform. SMB MediaLabs launched in July 2023 as a managed service via insertion orders. Now, in partnership with PubMatic, enterprise-level and large holding company buyers and publishers offering premium, brand-safe inventory across CTV, video, mobile and more will be able to connect marketers to this attractive audience-segment through PubMatic. Plus, SMB MediaLabs advertisers will be able to connect to these data segments directly via PubMatic's self-service Convert platform, a flexible, integrated white-label tech solution for retailers and marketplaces.</p>


INTU

PUBM

Pubmatic Forges Partnership With Intuit SMB Medialabs To Advance B2B Advertising With Privacy-Protective Solutions

<p>B. Riley Securities  analyst Eric Wold   downgrades Brunswick (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BC#NYSE">BC</a>) from Buy to Neutral and lowers the price target from $95 to $88.</p>


Downgrades

B. Riley Securities Downgrades Brunswick to Neutral, Lowers Price Target to $88

Warning: ALLK is at high risk of performing badly

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:&nbsp...

Biotech Alert: Searches spiking for these stocks today

TD Cowen analyst Joseph Thome maintained a Hold rating on Allakos (ALLK – Research Report) today. The company's shares closed yesterday at $1.41. T...

Allakos (ALLK) Gets a Hold from TD Cowen

Allakos GAAP EPS of -$0.21 beats by $0.03

Barclays analyst Carter Gould maintained a Sell rating on Allakos (ALLK – Research Report) today and set a price target of $1.00. The company's sha...

Allakos (ALLK) Gets a Sell from Barclays

Allakos Runs Up Into A Near-Term Catalyst

Leerink Partners analyst Thomas Smith reiterated a Hold rating on Allakos (ALLK – Research Report) yesterday and set a price target of $2.00. Thoma...

Cautious Hold Rating for Allakos Amid Uncertain Clinical and Financial Outlook

Allakos ( ($ALLK) ) has provided an announcement. Allakos Inc. has entered into a Lease Termination Agreement with its landlord, significantly alte...

Allakos Inc. Alters Lease Agreement for Cost Savings

Allakos ( ($ALLK) ) has released its Q3 earnings. Here is a breakdown of the information Allakos presented to its investors. Allakos Inc. is a biot...

Allakos Reports Q3 2024 Results and Research Progress

AKBA

ALLK

APVO

CNSP

CRMD

CYCC

DBVT

GNPX

IMUX

MBIO

ONCT

SGMO

SYRS

Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc.  - ALLK

Legal

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK

Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition

General

Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024

Earnings

Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Allakos Provides Business Update and Reports First Quarter 2024 Financial Results

Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria

Health Care

Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile

Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results

Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers

Comments

Allakos

Notizie

Ultime notizie per Allakos (NASDAQ:ALLK) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO